See also this year's filing and all EDGAR filings for this company.
PDF Report 0001070336_2019_Achillion_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001070336, Achillion Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 275,380,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,137,000 |
| 3 | remainder_Assets | 341,000 |
| 4 | LiabilitiesCurrent | 11,829,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 17,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 23,894,693 |
| 9 | ResearchAndDevelopmentExpense | 48,202,785 |
| 10 | remainder_Expenses | 73,669 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 9,664,548 |
| 13 | remainder_ComprehensiveNetIncome | -539,184 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 277,858,000 |
| 1 | Liabilities | 11,846,000 |
| 2 | Expenses | 72,171,147 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 266,012,000 |
| 5 | NetIncome | -62,506,599 |
| 6 | ComprehensiveNetIncome | -62,776,191 |
| 7 | BaseVar | 186,039,440 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.57 |
| 9 | EconomicCapitalRatio | 4.08 |
Edgar->Model Mapping
Feature Distribution
Change over Time
